AUS
NZ
UK
CA
USA
IND
Highlights
- HOPE Therapeutics™, Inc., a subsidiary of NRx Pharmaceuticals, focuses on innovations in medical and technological applications for neuropsychiatric care.
- Dr. David Feifel, Founder of Kadima Neuropsychiatry Institute, was featured in a CNN program addressing ketamine's scientific and societal aspects.
- Kadima Neuropsychiatry Institute is planned to become the flagship clinic of HOPE Therapeutics following the completion of an acquisition.
HOPE Therapeutics™, Inc., operates in the medical and technology field with a focus on addressing complex neuropsychiatric challenges. As a wholly-owned subsidiary of NRx Pharmaceuticals, Inc.(NASDAQ:NRXP) , the organization integrates advanced research with clinical innovation to expand treatment options for mental health conditions. The sector’s advancements highlight the exploration of novel therapies, including ketamine-based treatments.
Feature on Dr. David Feifel
Dr. David Feifel, Founder of Kadima Neuropsychiatry Institute, recently appeared as an expert in a CNN program hosted by Dr. Sanjay Gupta. The segment, titled “Special K: The Science & Stigma of Ketamine,” examined the use of ketamine in addressing mental health conditions. Dr. Feifel’s contributions spotlight the evolving dialogue around neuropsychiatric treatment approaches.
Kadima Neuropsychiatry Institute
Kadima Neuropsychiatry Institute has been designated as the planned flagship clinic for HOPE Therapeutics, pending the completion of an acquisition. This institute focuses on cutting-edge neuropsychiatric treatment strategies, providing specialized care to address severe mental health challenges. The integration of this clinic into the organization’s portfolio aligns with efforts to broaden access to advanced care solutions.
Ketamine’s Role in Mental Health Treatments
The role of ketamine in neuropsychiatric care has gained attention due to its applications in treatment-resistant mental health conditions. The CNN program explored the scientific basis of ketamine’s effects while addressing the social perceptions and misconceptions surrounding its use. These discussions contribute to broader awareness of innovative medical approaches in mental health care.
